Skip to content

Aura Biosciences, Inc. AURA Total Current Assets

Total Current Assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$59.17B-17.3%
Merck & Co. logo
Merck & Co.MRK
$35.02B-1.4%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$452.95M+315%
UroGen Pharma logo
UroGen PharmaURGN
$237.46M+0.1%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$696.11M-1.7%
CG Oncology logo
CG OncologyCGON
$1.1B+57.2%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s total current assets?
Aura Biosciences, Inc. (AURA) reported total current assets of $118.5M in Q1 2026.
How has Aura Biosciences, Inc.'s total current assets changed year-over-year?
Aura Biosciences, Inc.'s total current assets decreased by 11.9% year-over-year, from $134.52M to $118.5M.
What is the long-term trend for Aura Biosciences, Inc.'s total current assets?
Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s total current assets has grown at a 52.0% compound annual growth rate (CAGR), from $18.46M to $149.74M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.